Astera Labs (NASDAQ:ALAB) Stock Rating Upgraded by Wall Street Zen

Astera Labs (NASDAQ:ALAB) was upgraded by equities researchers at Wall Street Zen from a “hold” rating to a “buy” rating in a research report issued to clients and investors on Saturday.

Other analysts have also issued reports about the stock. TD Cowen assumed coverage on shares of Astera Labs in a research report on Wednesday, October 1st. They issued a “hold” rating and a $200.00 price target on the stock. Evercore ISI upped their target price on Astera Labs from $104.00 to $215.00 and gave the company an “outperform” rating in a research note on Wednesday, August 6th. CICC Research started coverage on Astera Labs in a report on Friday, August 29th. They set an “outperform” rating and a $190.00 target price on the stock. Stifel Nicolaus boosted their price target on Astera Labs from $174.00 to $185.00 and gave the stock a “buy” rating in a report on Friday. Finally, Zacks Research lowered Astera Labs from a “strong-buy” rating to a “hold” rating in a research note on Monday, October 6th. Fifteen analysts have rated the stock with a Buy rating and eight have assigned a Hold rating to the company. Based on data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $162.06.

Astera Labs Stock Performance

Shares of ALAB stock opened at $159.80 on Friday. The stock has a fifty day moving average price of $199.68 and a 200 day moving average price of $128.80. The stock has a market cap of $26.56 billion, a PE ratio of 285.36, a P/E/G ratio of 3.98 and a beta of 1.43. Astera Labs has a 1 year low of $47.13 and a 1 year high of $262.90.

Astera Labs (NASDAQ:ALAB) last announced its quarterly earnings results on Tuesday, August 5th. The company reported $0.44 earnings per share for the quarter, beating analysts’ consensus estimates of $0.33 by $0.11. Astera Labs had a return on equity of 9.53% and a net margin of 16.54%.The business had revenue of $191.93 million during the quarter, compared to analysts’ expectations of $172.46 million. During the same quarter last year, the business posted $0.13 earnings per share. The business’s revenue for the quarter was up 149.5% on a year-over-year basis. Astera Labs has set its Q3 2025 guidance at 0.380-0.390 EPS. As a group, equities research analysts predict that Astera Labs will post 0.34 earnings per share for the current year.

Insider Transactions at Astera Labs

In other news, Director Stefan A. Dyckerhoff sold 25,000 shares of the company’s stock in a transaction dated Thursday, August 7th. The shares were sold at an average price of $173.42, for a total transaction of $4,335,500.00. Following the completion of the transaction, the director owned 99,154 shares of the company’s stock, valued at $17,195,286.68. This represents a 20.14% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this link. Also, CFO Michael Truett Tate sold 100,000 shares of the firm’s stock in a transaction that occurred on Thursday, August 7th. The stock was sold at an average price of $171.38, for a total transaction of $17,138,000.00. Following the completion of the sale, the chief financial officer directly owned 518,996 shares in the company, valued at $88,945,534.48. This represents a 16.16% decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last three months, insiders sold 1,092,997 shares of company stock valued at $192,231,120. Corporate insiders own 12.50% of the company’s stock.

Hedge Funds Weigh In On Astera Labs

A number of large investors have recently bought and sold shares of the stock. Warren Street Wealth Advisors LLC purchased a new stake in shares of Astera Labs during the 3rd quarter valued at $202,000. Perigon Wealth Management LLC acquired a new position in Astera Labs in the third quarter valued at $231,000. Highland Capital Management LLC boosted its holdings in Astera Labs by 199.5% in the third quarter. Highland Capital Management LLC now owns 12,581 shares of the company’s stock valued at $2,463,000 after acquiring an additional 8,381 shares during the last quarter. HBK Sorce Advisory LLC purchased a new stake in Astera Labs during the third quarter valued at about $260,000. Finally, Yeomans Consulting Group Inc. acquired a new stake in Astera Labs during the third quarter worth about $488,000. Hedge funds and other institutional investors own 60.47% of the company’s stock.

Astera Labs Company Profile

Astera Labs, Inc designs, manufactures, and sells semiconductor-based connectivity solutions for cloud and AI infrastructure. Its Intelligent Connectivity Platform is comprised of a portfolio of data, network, and memory connectivity products, which are built on a unifying software-defined architecture that enables customers to deploy and operate high performance cloud and AI infrastructure at scale.